Biogen Inc.

Location

Massachusetts

Founded

1978-02-28

Risk Signals

6605 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Biological Products, Except Diagnostic Substances, Commercial Physical and Biological Research), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Biogen Inc.

Live alerts from global media, monitored by Business Radar

Top Development & Construction Projects: Kendall Common – MIT's Volpe Redevelopment & Biogen's New Global HQ - Boston Real Estate Times

2025-04-17 (bostonrealestatetimes.com)

Top Development & Construction Projects: Kendall Common – MIT's Volpe Redevelopment & Biogen's New Global HQ - Boston Real Estate Times

Project Overview Kendall Common is a transformative mixed-use development situated on the 14-acre site of the former Volpe National Transportation Systems Center in Cambridge's Kendall Square. MITIMCo acquired the property […]

Read more
News | Blackstone's BioMed adds biotech hub in Boston area with added demand

2025-03-24 (costar.com)

News | Blackstone's BioMed adds biotech hub in Boston area with added demand

Deal includes build-to-suit global headquarters for Biogen

Read more
Court Rules Biogen Not to Blame for Subtenants’ Woes -

2025-01-07 (bankerandtradesman.com)

Court Rules Biogen Not to Blame for Subtenants’ Woes -

A Suffolk Superior Court judge dismissed a biomanufacturing company’s lawsuit that claimed disruption caused by a Kendall Square development caused it to lose virtually all of its long-term contracts.

Read more
Norges Bank Buys Stake In Kendall Square Lab Developments At $1.7B Valuation

2023-11-14 (bisnow.com)

Norges Bank Buys Stake In Kendall Square Lab Developments At $1.7B Valuation

The Norwegian sovereign wealth fund manager bought a 45% stake in two Boston Properties life sciences projects for $746.4M.

Read more
BXP Purchases Biogen Headquarters in Cambridge for Approximately $592 Million - Boston Real Estate Times

2022-09-20 (bostonrealestatetimes.com)

BXP Purchases Biogen Headquarters in Cambridge for Approximately $592 Million - Boston Real Estate Times

BOSTON–BXP, the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced that it completed the acquisition of 125 Broadway, a six-story, 271,000 square foot […]

Read more
Manufacturing, Award Of Merit: Biogen 2019 RTP DS LSM Tech Upgrade | 2020-10-28 | Engineering News-Record

2020-10-28 (enr.com)

Manufacturing, Award Of Merit: Biogen 2019 RTP DS LSM Tech Upgrade | 2020-10-28 | Engineering News-Record

Biogen 2019 RTP DS LSM Tech Upgrade Research Triangle Park, N.C. Award of Merit Owner: Biogen Inc. Lead Design Firm/MEP Engineer: CRB Consulting Engineers Inc. Contractor: DPR Construction Structural Engineer: Ardurra Group A design-build team led by contractor DPR Construction upgraded Biogen's plant in North Carolina's Research Triangle Park to help ease bottlenecks in one of the plant's purification suites. The same team conducted a 2017 upgrade at the plant and was able to leverage its familiarity with the facility's complexities to speed delivery. As . . .

Read more
News | Blackstone's BioMed adds biotech hub in Boston area with added demand

(costar.com)

News | Blackstone's BioMed adds biotech hub in Boston area with added demand

Deal includes build-to-suit global headquarters for Biogen

Read more

Never miss a headline about Biogen Inc.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages